Key Drivers
- Cash Generation
- Thin Margins
- Heavy Leverage
AIAI Summary
ALHC has shifted from a “cheap healthcare plan” to a scaling managed-care growth story with strong membership, revenue, and free-cash-flow momentum, but at ~235x earnings and with thin margins plus interest costs that already exceed EBIT, the stock now depends on continued execution and stable medical-cost trends to justify its rerated valuation.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Generation
- •Thin Margins
- •Heavy Leverage
ALHC has strong scale and solid cash generation, but thin margins, weak solvency, and a very demanding valuation make the stock look expensive despite recent quarterly improvement.
Price Behavior
Key Price Behavior Insights:
- •Higher highs
- •Near resistance
- •Overbought risk
Over the last month, ALHC surged from about $14 to the mid-$20s in a strong uptrend with higher highs and higher lows, but it is now short-term extended near $24 resistance and should hold the $21.3–$21.7 support zone to stay constructive.
Sharp breakout from about $14 to the mid-$20s suggests an event-driven, volatile advance
Sentiment & News
Key News Insights:
- •Share surge
- •Conference spotlight
- •Insider selling
Alignment Healthcare surged on strong trading momentum and conference visibility, but the rally was tempered by overvaluation concerns and recurring insider sales.
The stock's momentum looks strong, but valuation and insider-sale headlines may limit near-term upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings